Correlation Between Unrivaled Brands and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unrivaled Brands and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unrivaled Brands and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unrivaled Brands and Aquestive Therapeutics, you can compare the effects of market volatilities on Unrivaled Brands and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unrivaled Brands with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unrivaled Brands and Aquestive Therapeutics.
Diversification Opportunities for Unrivaled Brands and Aquestive Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Unrivaled and Aquestive is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Unrivaled Brands and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Unrivaled Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unrivaled Brands are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Unrivaled Brands i.e., Unrivaled Brands and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Unrivaled Brands and Aquestive Therapeutics
Given the investment horizon of 90 days Unrivaled Brands is expected to generate 3.38 times less return on investment than Aquestive Therapeutics. In addition to that, Unrivaled Brands is 1.12 times more volatile than Aquestive Therapeutics. It trades about 0.03 of its total potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest 86.00 in Aquestive Therapeutics on September 1, 2024 and sell it today you would earn a total of 423.00 from holding Aquestive Therapeutics or generate 491.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 24.84% |
| Values | Daily Returns |
Unrivaled Brands vs. Aquestive Therapeutics
Performance |
| Timeline |
| Unrivaled Brands |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aquestive Therapeutics |
Unrivaled Brands and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unrivaled Brands and Aquestive Therapeutics
The main advantage of trading using opposite Unrivaled Brands and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unrivaled Brands position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Unrivaled Brands vs. MPX International Corp | Unrivaled Brands vs. 4Front Ventures Corp | Unrivaled Brands vs. StateHouse Holdings | Unrivaled Brands vs. Decibel Cannabis |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |